Kim Schenk is speaking on two panels during this conference, “Patent Valuation Versus Patent Damages: Is There/Should There Be a Difference?” and “What’s New in Patent Damages.” This conference is for corporate counsel, intellectual property litigators, and those involved in the ever-changing patent environment
For more information, click here.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...